You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Ischemia Reperfusion Injury Therapeutics Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Ischemia Reperfusion Injury Therapeutics Market
The research report studies the Ischemia Reperfusion Injury Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Ischemia Reperfusion Injury Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Ischemia Reperfusion Injury Therapeutics Scope and Segment
The global Ischemia Reperfusion Injury Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ischemia Reperfusion Injury Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
by Application, this report covers the following segments
Global Ischemia Reperfusion Injury Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Ischemia Reperfusion Injury Therapeutics key players in this market include:
Nyken B.V.
Omeros Corporation
Opsona Therapeutics Limited
Orexo AB
Pharming Group N.V.
PledPharma AB
Prolong Pharmaceuticals
Proteo, Inc.
Prothix BV
Stealth BioTherapeutics Inc.
Zealand Pharma A/S
Amyndas Pharmaceuticals LLC
Angion Biomedica Corp.
Antipodean Pharmaceuticals, Inc.
Bayer AG
Biomedica Management Corporation
Bolder Biotechnology, Inc.
Curatis Pharma GmbH
Ensemble Therapeutics Corporation
Erimos Pharmaceuticals, LLC
Gilead Sciences, Inc.
1 Market Overview of Ischemia Reperfusion Injury Therapeutics
1.1 Ischemia Reperfusion Injury Therapeutics Market Overview
1.1.1 Ischemia Reperfusion Injury Therapeutics Product Scope
1.1.2 Ischemia Reperfusion Injury Therapeutics Market Status and Outlook
1.2 Global Ischemia Reperfusion Injury Therapeutics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Ischemia Reperfusion Injury Therapeutics Market Size by Region (2016-2027)
1.4 Global Ischemia Reperfusion Injury Therapeutics Historic Market Size by Region (2016-2021)
1.5 Global Ischemia Reperfusion Injury Therapeutics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
1.6.1 North America Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
1.6.2 Europe Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
1.6.3 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
1.6.4 Latin America Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
1.6.5 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size (2016-2027)
2 Ischemia Reperfusion Injury Therapeutics Market Overview by Type
2.1 Global Ischemia Reperfusion Injury Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Ischemia Reperfusion Injury Therapeutics Historic Market Size by Type (2016-2021)
2.3 Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Type (2022-2027)
2.4 ANV-6L15
2.5 APP-103
2.6 BAY-606583
2.7 EP-80317
2.8 GS-459679
2.9 KN-93
2.10 LH-021
2.11 Others
3 Ischemia Reperfusion Injury Therapeutics Market Overview by Application
3.1 Global Ischemia Reperfusion Injury Therapeutics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Ischemia Reperfusion Injury Therapeutics Historic Market Size by Application (2016-2021)
3.3 Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Application (2022-2027)
3.4 Clinic
3.5 Hospital
3.6 Others
4 Ischemia Reperfusion Injury Therapeutics Competition Analysis by Players
4.1 Global Ischemia Reperfusion Injury Therapeutics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury Therapeutics as of 2020)
4.3 Date of Key Players Enter into Ischemia Reperfusion Injury Therapeutics Market
4.4 Global Top Players Ischemia Reperfusion Injury Therapeutics Headquarters and Area Served
4.5 Key Players Ischemia Reperfusion Injury Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Ischemia Reperfusion Injury Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Nyken B.V.
5.1.1 Nyken B.V. Profile
5.1.2 Nyken B.V. Main Business
5.1.3 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.1.4 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.1.5 Nyken B.V. Recent Developments
5.2 Omeros Corporation
5.2.1 Omeros Corporation Profile
5.2.2 Omeros Corporation Main Business
5.2.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.2.4 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.2.5 Omeros Corporation Recent Developments
5.3 Opsona Therapeutics Limited
5.3.1 Opsona Therapeutics Limited Profile
5.3.2 Opsona Therapeutics Limited Main Business
5.3.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.3.4 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.3.5 Orexo AB Recent Developments
5.4 Orexo AB
5.4.1 Orexo AB Profile
5.4.2 Orexo AB Main Business
5.4.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.4.4 Orexo AB Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.4.5 Orexo AB Recent Developments
5.5 Pharming Group N.V.
5.5.1 Pharming Group N.V. Profile
5.5.2 Pharming Group N.V. Main Business
5.5.3 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.5.4 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.5.5 Pharming Group N.V. Recent Developments
5.6 PledPharma AB
5.6.1 PledPharma AB Profile
5.6.2 PledPharma AB Main Business
5.6.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.6.4 PledPharma AB Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.6.5 PledPharma AB Recent Developments
5.7 Prolong Pharmaceuticals
5.7.1 Prolong Pharmaceuticals Profile
5.7.2 Prolong Pharmaceuticals Main Business
5.7.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.7.4 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.7.5 Prolong Pharmaceuticals Recent Developments
5.8 Proteo Inc.
5.8.1 Proteo Inc. Profile
5.8.2 Proteo Inc. Main Business
5.8.3 Proteo Inc. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.8.4 Proteo Inc. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.8.5 Proteo Inc. Recent Developments
5.9 Prothix BV
5.9.1 Prothix BV Profile
5.9.2 Prothix BV Main Business
5.9.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.9.4 Prothix BV Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.9.5 Prothix BV Recent Developments
5.10 Stealth BioTherapeutics Inc.
5.10.1 Stealth BioTherapeutics Inc. Profile
5.10.2 Stealth BioTherapeutics Inc. Main Business
5.10.3 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.10.4 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.10.5 Stealth BioTherapeutics Inc. Recent Developments
5.11 Zealand Pharma A/S
5.11.1 Zealand Pharma A/S Profile
5.11.2 Zealand Pharma A/S Main Business
5.11.3 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.11.4 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.11.5 Zealand Pharma A/S Recent Developments
5.12 Amyndas Pharmaceuticals LLC
5.12.1 Amyndas Pharmaceuticals LLC Profile
5.12.2 Amyndas Pharmaceuticals LLC Main Business
5.12.3 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.12.4 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.12.5 Amyndas Pharmaceuticals LLC Recent Developments
5.13 Angion Biomedica Corp.
5.13.1 Angion Biomedica Corp. Profile
5.13.2 Angion Biomedica Corp. Main Business
5.13.3 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.13.4 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.13.5 Angion Biomedica Corp. Recent Developments
5.14 Antipodean Pharmaceuticals Inc.
5.14.1 Antipodean Pharmaceuticals Inc. Profile
5.14.2 Antipodean Pharmaceuticals Inc. Main Business
5.14.3 Antipodean Pharmaceuticals Inc. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.14.4 Antipodean Pharmaceuticals Inc. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.14.5 Antipodean Pharmaceuticals Inc. Recent Developments
5.15 Bayer AG
5.15.1 Bayer AG Profile
5.15.2 Bayer AG Main Business
5.15.3 Bayer AG Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.15.4 Bayer AG Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.15.5 Bayer AG Recent Developments
5.16 Biomedica Management Corporation
5.16.1 Biomedica Management Corporation Profile
5.16.2 Biomedica Management Corporation Main Business
5.16.3 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.16.4 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.16.5 Biomedica Management Corporation Recent Developments
5.17 Bolder Biotechnology Inc.
5.17.1 Bolder Biotechnology Inc. Profile
5.17.2 Bolder Biotechnology Inc. Main Business
5.17.3 Bolder Biotechnology Inc. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.17.4 Bolder Biotechnology Inc. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.17.5 Bolder Biotechnology Inc. Recent Developments
5.18 Curatis Pharma GmbH
5.18.1 Curatis Pharma GmbH Profile
5.18.2 Curatis Pharma GmbH Main Business
5.18.3 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.18.4 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.18.5 Curatis Pharma GmbH Recent Developments
5.19 Ensemble Therapeutics Corporation
5.19.1 Ensemble Therapeutics Corporation Profile
5.19.2 Ensemble Therapeutics Corporation Main Business
5.19.3 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.19.4 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.19.5 Ensemble Therapeutics Corporation Recent Developments
5.20 Erimos Pharmaceuticals, LLC
5.20.1 Erimos Pharmaceuticals, LLC Profile
5.20.2 Erimos Pharmaceuticals, LLC Main Business
5.20.3 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.20.4 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.20.5 Erimos Pharmaceuticals, LLC Recent Developments
5.21 Gilead Sciences Inc.
5.21.1 Gilead Sciences Inc. Profile
5.21.2 Gilead Sciences Inc. Main Business
5.21.3 Gilead Sciences Inc. Ischemia Reperfusion Injury Therapeutics Products, Services and Solutions
5.21.4 Gilead Sciences Inc. Ischemia Reperfusion Injury Therapeutics Revenue (US$ Million) & (2016-2021)
5.21.5 Gilead Sciences Inc. Recent Developments
6 North America
6.1 North America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ischemia Reperfusion Injury Therapeutics Market Dynamics
11.1 Ischemia Reperfusion Injury Therapeutics Industry Trends
11.2 Ischemia Reperfusion Injury Therapeutics Market Drivers
11.3 Ischemia Reperfusion Injury Therapeutics Market Challenges
11.4 Ischemia Reperfusion Injury Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125